U.S. Immigration Law Both Helps And Hinders Foreign Researchers

New policies may make it more difficult for them to work temporarily, but may make it easier for them to get permanent visas Universities, industries, and government agencies that employ foreign scientists see the 1990 Immigration Act, which revamps the visa application process for skilled workers and the quotas of temporary and permanent visas issued, as a mixed blessing. The 110-page law, signed by President Bush last November, triples the number of permanent visas for skilled workers to 1

Written byRobin Eisner
| 8 min read

Register for free to listen to this article
Listen with Speechify
0:00
8:00
Share

Universities, industries, and government agencies that employ foreign scientists see the 1990 Immigration Act, which revamps the visa application process for skilled workers and the quotas of temporary and permanent visas issued, as a mixed blessing.

The 110-page law, signed by President Bush last November, triples the number of permanent visas for skilled workers to 140,000 each year and makes the application process easier and quicker for some of these aliens. But it will significantly lengthen the application process for temporary visas, limit their number to 65,000 a year, and increase the cost of bringing these immigrants to the United States. Some worry that this could hurt certain industry and university operations that have long relied on foreign scientists on temporary visas to fill vital positions.

Other critics also fear that the new law, scheduled to take effect in October, could create a glut of foreign scientist immigrants who will ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies